149 related articles for article (PubMed ID: 8894608)
1. Sigma 1 receptor subtype is involved in the relief of behavioral despair in the mouse forced swimming test.
Matsuno K; Kobayashi T; Tanaka MK; Mita S
Eur J Pharmacol; 1996 Oct; 312(3):267-71. PubMed ID: 8894608
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of acute and repeated administrations of sigma receptor agonists on behavioral despair in mice exposed to tail suspension.
Ukai M; Maeda H; Nanya Y; Kameyama T; Matsuno K
Pharmacol Biochem Behav; 1998 Nov; 61(3):247-52. PubMed ID: 9768559
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of sigma ligand-activated receptor subtypes that modulate NMDA-evoked [3H]-noradrenaline release in rat hippocampal slices.
Monnet FP; de Costa BR; Bowen WD
Br J Pharmacol; 1996 Sep; 119(1):65-72. PubMed ID: 8872358
[TBL] [Abstract][Full Text] [Related]
4. A-Current down-modulated by sigma receptor in frog pituitary melanotrope cells through a G protein-dependent pathway.
Soriani O; Foll FL; Roman F; Monnet FP; Vaudry H; Cazin L
J Pharmacol Exp Ther; 1999 Apr; 289(1):321-8. PubMed ID: 10087020
[TBL] [Abstract][Full Text] [Related]
5. Sigma (sigma1) receptor mediated anti-depressant-like effects of neurosteroids in the Porsolt forced swim test.
Reddy DS; Kaur G; Kulkarni SK
Neuroreport; 1998 Sep; 9(13):3069-73. PubMed ID: 9804318
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of sigma ligands on the N-methyl-D-aspartate response in the CA1 and CA3 regions of the dorsal hippocampus: effect of mossy fiber lesioning.
Debonnel G; Bergeron R; Monnet FP; De Montigny C
Neuroscience; 1996 Apr; 71(4):977-87. PubMed ID: 8684626
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase C-dependent potentiation of intracellular calcium influx by sigma1 receptor agonists in rat hippocampal neurons.
Monnet FP; Morin-Surun MP; Leger J; Combettes L
J Pharmacol Exp Ther; 2003 Nov; 307(2):705-12. PubMed ID: 12975497
[TBL] [Abstract][Full Text] [Related]
8. Phencyclidine impairs latent learning in mice: interaction between glutamatergic systems and sigma(1) receptors.
Noda A; Noda Y; Kamei H; Ichihara K; Mamiya T; Nagai T; Sugiura S; Furukawa H; Nabeshima T
Neuropsychopharmacology; 2001 Apr; 24(4):451-60. PubMed ID: 11182540
[TBL] [Abstract][Full Text] [Related]
9. NE-100, a novel potent sigma ligand, preferentially binds to sigma 1 binding sites in guinea pig brain.
Chaki S; Tanaka M; Muramatsu M; Otomo S
Eur J Pharmacol; 1994 Jan; 251(1):R1-2. PubMed ID: 8137864
[TBL] [Abstract][Full Text] [Related]
10. Ameliorating effect of SA4503, a novel sigma 1 receptor agonist, on memory impairments induced by cholinergic dysfunction in rats.
Senda T; Matsuno K; Okamoto K; Kobayashi T; Nakata K; Mita S
Eur J Pharmacol; 1996 Nov; 315(1):1-10. PubMed ID: 8960858
[TBL] [Abstract][Full Text] [Related]
11. Involvement of sigma receptors in the modulation of the glutamatergic/NMDA neurotransmission in the dopaminergic systems.
Gronier B; Debonnel G
Eur J Pharmacol; 1999 Mar; 368(2-3):183-96. PubMed ID: 10193654
[TBL] [Abstract][Full Text] [Related]
12. Activation of sigma1 receptor subtype leads to neuroprotection in the rat primary neuronal cultures.
Nakazawa M; Matsuno K; Mita S
Neurochem Int; 1998 Apr; 32(4):337-43. PubMed ID: 9596556
[TBL] [Abstract][Full Text] [Related]
13. Sigma 1 receptor subtype is involved in the facilitation of cortical dopaminergic transmission in the rat brain.
Kobayashi T; Matsuno K; Murai M; Mita S
Neurochem Res; 1997 Sep; 22(9):1105-9. PubMed ID: 9251100
[TBL] [Abstract][Full Text] [Related]
14. Behavioral evidence for modulation by sigma ligands of (+)MK-801-induced hyperlocomotion in monoamine-depleted mice.
Okuyama S; Imagawa Y; Tomisawa K
Neuropharmacology; 1996 Apr; 35(4):467-74. PubMed ID: 8793909
[TBL] [Abstract][Full Text] [Related]
15. Binding properties of SA4503, a novel and selective sigma 1 receptor agonist.
Matsuno K; Nakazawa M; Okamoto K; Kawashima Y; Mita S
Eur J Pharmacol; 1996 Jun; 306(1-3):271-9. PubMed ID: 8813641
[TBL] [Abstract][Full Text] [Related]
16. (+)-SKF-10,047 and dextromethorphan ameliorate conditioned fear stress through the activation of phenytoin-regulated sigma 1 sites.
Kamei H; Kameyama T; Nabeshima T
Eur J Pharmacol; 1996 Mar; 299(1-3):21-8. PubMed ID: 8901003
[TBL] [Abstract][Full Text] [Related]
17. Effects of sigma(1) receptor agonist SA4503 and neuroactive steroids on performance in a radial arm maze task in rats.
Zou LB; Yamada K; Sasa M; Nakata Y; Nabeshima T
Neuropharmacology; 2000 Jul; 39(9):1617-27. PubMed ID: 10854906
[TBL] [Abstract][Full Text] [Related]
18. Effect of short-term and long-term treatments with sigma ligands on the N-methyl-D-aspartate response in the CA3 region of the rat dorsal hippocampus.
Bergeron R; de Montigny C; Debonnel G
Br J Pharmacol; 1997 Apr; 120(7):1351-9. PubMed ID: 9105712
[TBL] [Abstract][Full Text] [Related]
19. Effect of SA4503, a novel sigma1 receptor agonist, against glutamate neurotoxicity in cultured rat retinal neurons.
Senda T; Mita S; Kaneda K; Kikuchi M; Akaike A
Eur J Pharmacol; 1998 Jan; 342(1):105-11. PubMed ID: 9544798
[TBL] [Abstract][Full Text] [Related]
20. 3,4-dihydro-2(1H)-quinolinone as a novel antidepressant drug: synthesis and pharmacology of 1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-3,4- dihydro-5-methoxy-2(1H)-quinolinone and its derivatives.
Oshiro Y; Sakurai Y; Sato S; Kurahashi N; Tanaka T; Kikuchi T; Tottori K; Uwahodo Y; Miwa T; Nishi T
J Med Chem; 2000 Jan; 43(2):177-89. PubMed ID: 10649973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
